TECON BIOLOGYLTD Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hui Cheng
Chief executive officer
CN¥600.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 18.1yrs |
CEO ownership | n/a |
Management average tenure | 13.3yrs |
Board average tenure | 1.9yrs |
Recent management updates
Recent updates
TECON BIOLOGY Co.LTD (SZSE:002100) Could Be Riskier Than It Looks
Oct 28TECON BIOLOGYLTD (SZSE:002100) Is Carrying A Fair Bit Of Debt
Sep 26Sentiment Still Eluding TECON BIOLOGY Co.LTD (SZSE:002100)
Jul 12TECON BIOLOGYLTD (SZSE:002100) Is Making Moderate Use Of Debt
May 11Why Investors Shouldn't Be Surprised By TECON BIOLOGY Co.LTD's (SZSE:002100) Low P/S
Apr 12CEO
Hui Cheng (59 yo)
18.1yrs
Tenure
CN¥600,000
Compensation
Mr. Hui Cheng serves as General Manager and has been Director at Tecon Biology Co., Ltd. since December 20, 2006. Mr. Cheng is a senior veterinary surgeon.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | no data | CN¥600.00k | no data | |
Financial Director | 18.1yrs | CN¥300.00k | no data | |
Legal Director | 8.8yrs | CN¥200.00k | no data | |
Human Resources Director | 8.8yrs | CN¥250.00k | no data | |
Audit Director | no data | CN¥250.00k | no data | |
Deputy GM & Director | no data | CN¥420.00k | no data | |
Board Secretary | 17.8yrs | CN¥300.00k | no data | |
Accounting Supervisor | no data | no data | no data |
13.3yrs
Average Tenure
55yo
Average Age
Experienced Management: 002100's management team is seasoned and experienced (13.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | 18.1yrs | CN¥600.00k | no data | |
Deputy GM & Director | 6.8yrs | CN¥420.00k | no data | |
Member of Supervisory Board | 8.8yrs | no data | no data | |
Non-Independent Director | 1.9yrs | no data | no data | |
Independent Director | 1.9yrs | CN¥91.70k | no data | |
Independent Director | 1.9yrs | CN¥91.70k | no data | |
Independent Director | 1.9yrs | CN¥91.70k | no data | |
Chairman of Supervisory Board | 1.9yrs | no data | no data | |
Director | less than a year | no data | no data |
1.9yrs
Average Tenure
53yo
Average Age
Experienced Board: 002100's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/04 06:05 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TECON BIOLOGY Co.LTD is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jia Chen | Changjiang Securities Co. LTD. |
Xie Zhiyou | China Galaxy Securities Co., Ltd. |
Junhao Fan | China International Capital Corporation Limited |